Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer
Cells · 2024
DOI: 10.3390/cells14010018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Tycho de Bakker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Drug Resistance, Neoplasm, Chemoradiotherapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rose et Jean Hoguet foundation, Jules Bordet Foundation.
Abstract (Originalsprache)
Definitive chemoradiotherapy (CRT) is a cornerstone of treatment for locoregionally advanced head and neck cancer (HNC). Research is ongoing on how to improve the tumor response to treatment and limit normal tissue toxicity. A major limitation in that regard is the growing occurrence of intrinsic or acquired treatment resistance in advanced cases. In this review, we will discuss how overexpression of efflux pumps, perturbation of apoptosis-related factors, increased expression of antioxidants, glucose metabolism, metallotheionein expression, increased DNA repair, cancer stem cells, epithelial-mesenchymal transition, non-coding RNA and the tumour microenvironment contribute towards resistance of HNC to chemotherapy and/or radiotherapy. These mechanisms have been investigated for years and been exploited for therapeutic gain in resistant patients, paving the way to the development of new promising drugs. Since in vitro studies on resistance requires a suitable model, we will also summarize published techniques and treatment schedules that have been shown to generate acquired resistance to chemo- and/or radiotherapy that most closely mimics the clinical scenario.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiotherapy Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
- Medical Physics Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
ORCID-Profile: Philippe Martinive, Sébastien Penninckx
Förderung
- Rose et Jean Hoguet foundation
- Jules Bordet Foundation
Zitieren
APA
de Bakker, T., Maes, A., Dragan, T., Martinive, P., Penninckx, S., & Van Gestel, D. (2024). Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer. Cells. https://doi.org/10.3390/cells14010018
Vancouver
de Bakker T, Maes A, Dragan T, Martinive P, Penninckx S, Van Gestel D. Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer. Cells. 2024. doi:10.3390/cells14010018
BibTeX
@article{deBakker2024,
author = {de Bakker, Tycho and Maes, Anouk and Dragan, Tatiana and Martinive, Philippe and Penninckx, Sébastien and Van Gestel, Dirk},
title = {Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer},
journal = {Cells},
year = {2024},
doi = {10.3390/cells14010018}
}
EUVIMED